References:
  1. Mohebbi B, Sadeghipour P, Zolfaghari R, VadalĂ  G, Khalilipur E, Zahedmehr A, Diana D, Maadani M, Shakerian F, Kiani R, Hosseini Z, Rashidinejad A, Rouzitalab M, Khalesi S, Toulabi V, Sucato V, Di Fazio L, Taherian M, Amiripouya S, Ashuri S, Bayatian A, Naderi S, Bakhshandeh H, Moosavi J, Abdi S, Firouzi A, Alemzadeh-Ansari MJ, Galassi AR. Outcomes of chronic total occlusion percutaneous coronary intervention from the RAIAN (RAjaie - Iran) registry. Indian Heart J. 2023 Nov-Dec;75(6):429-435.
  2. Werner GS, Hildick-Smith D, Martin Yuste V, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, Di Mario C, Teruel L, Bufe A, Lauer B, Galassi AR, Louvard Y. Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO). EuroIntervention. 2023 Sep 18;19(7):571-579.
  3. Kim MH, Mitsudo K, Jin CD, Kim TH, Cho YR, Park JS, Park K, Park TH, Serebruany V. Long-term clinical outcomes after successful and failed recanalization to native chronic Total occlusion: Insights from the Busan chronic Total occlusion (B-CTO) Registry. Cardiovasc Revasc Med. 2016 Jun;17(4):229-32.
  4. Nathan A, Hashemzadeh M, Movahed MR. Percutaneous Coronary Intervention of Chronic Total Occlusion Associated with Higher Inpatient Mortality and Complications Compared With Non-CTO Lesions. Am J Med. 2023 Oct;136(10):994-999.
  5. Movahed MR. It is time to have better oversite and accountability in performing too many not indicated percutaneous coronary interventions in patients with chronic total occlusions. Int J Cardiol. 2019 Mar 1;278:38-39.